KORNITZER CAPITAL MANAGEMENT INC /KS - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
KORNITZER CAPITAL MANAGEMENT INC /KS ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,248,217
+12.0%
451,524
+5.8%
0.36%
+17.5%
Q2 2023$15,394,460
-5.0%
426,794
+0.6%
0.30%
-6.2%
Q1 2023$16,199,969
-6.8%
424,194
+38.9%
0.32%
-8.2%
Q4 2022$17,374,358
-1.9%
305,349
-31.8%
0.35%
-7.4%
Q3 2022$17,711,000
-10.2%
447,914
-0.0%
0.38%
-3.6%
Q2 2022$19,713,000
-9.6%
448,014
-18.1%
0.39%
+9.7%
Q1 2022$21,803,000
-0.8%
546,7150.0%0.36%
+9.5%
Q4 2021$21,983,000
+16.2%
546,715
+17.6%
0.33%
+13.1%
Q3 2021$18,913,000
-10.4%
464,9300.0%0.29%
-8.5%
Q2 2021$21,112,000
+23.0%
464,930
+12.9%
0.32%
+15.3%
Q1 2021$17,164,000
-2.4%
411,6950.0%0.28%
-7.7%
Q4 2020$17,583,000
+44.7%
411,695
-10.9%
0.30%
+25.2%
Q3 2020$12,149,000
-3.0%
462,300
-1.1%
0.24%
-5.9%
Q2 2020$12,527,000
+47.9%
467,265
-0.7%
0.25%
+25.9%
Q1 2020$8,469,000
+79.0%
470,750
+76.4%
0.20%
+139.3%
Q4 2019$4,732,000266,8950.08%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders